- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 13-02-2026: Press Release
13-02-2026 | 09:18 am
13-02-2026 | 09:18 am
NATCO Pharma's Chennai API unit inspection by the US FDA is classified as 'Voluntary Action Indicated' (VAI). This is a positive development, indicating no further regulatory action required, reducing compliance risk for the company.
No comments yet. Be the first to comment!